Chao-Cheng Lin, MD, PhD | Psychiatrist.com

Original Research

Antipsychotic Treatment and the Occurrence of Venous Thromboembolism: A 10-Year Nationwide Registry Study

September 15, 2013

Chao-Cheng Lin, Chi-Shin Wu, Chia-Ming Chang, et al

Letter to the Editor

Reply to Metabolic Syndrome in Inpatients Treated With Clozapine

June 15, 2011

Chao-Cheng Lin, Tung-Pine Su, Tzu Ting Chen

Original Research

Association of Weight Gain and Metabolic Syndrome in Patients Taking Clozapine: An 8-Year Cohort Study

November 30, 2010

Jen-Yeu Chen, Chao-Cheng Lin, Tung-Pine Su, et al

Original Research

Easy and Low-Cost Identification of Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotics: Artificial Neural Network and Logistic Regression Models

October 6, 2009

Ya-Mei Bai, Jen-Yeu Chen, Chao-Cheng Lin, et al

Original Research

Adiponectin as a Potential Biomarker for the Metabolic Syndrome in Chinese Patients Taking Clozapine for Schizophrenia

December 14, 2007

Jen-Yeu Chen, Wei-Shiung Yang, Yu-Chiao Chi, et al

Original Research

Risperidone for Severe Tardive Dyskinesia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study

November 15, 2003

Ya-Mei Bai, Chao-Cheng Lin, Shun-Chieh Yu